|
Re: CASH
|
4
|
Resverlogix Corp.
|
Oct 05, 2019 01:39AM
|
|
Madrid - Great Place to Announce A Deal
|
4
|
Resverlogix Corp.
|
May 31, 2017 10:14AM
|
|
Re: Contest Tally- Waste of board space
|
4
|
Resverlogix Corp.
|
Feb 12, 2019 05:15PM
|
|
Re: Competition
|
4
|
Resverlogix Corp.
|
Nov 29, 2021 01:24PM
|
|
Re: Pfizer sees strong demand for COVID pill as profits surge.
|
4
|
Resverlogix Corp.
|
May 04, 2022 09:34PM
|
|
Re: Apabetalone for non diabetics or normal cholesterol?
|
4
|
Resverlogix Corp.
|
Dec 10, 2019 11:28AM
|
|
Re: Now recruiting: ZEN-3694 and Talazoparib in Patients With Triple Negative Breast Cancer (TNBC)
|
4
|
Zenith Epigenetics
|
May 06, 2019 06:09PM
|
|
Re: Interesting read on the backlash to FDA's approval of aducanumab
|
4
|
Resverlogix Corp.
|
Jun 10, 2021 08:47PM
|
|
Re: Fda...
|
4
|
Resverlogix Corp.
|
Dec 08, 2019 03:28PM
|
|
Re: Warrants conversion!
|
4
|
Resverlogix Corp.
|
Nov 26, 2019 11:22AM
|
|
Re: Thoughts on ZCC
|
4
|
Zenith Epigenetics
|
Sep 05, 2021 12:27PM
|
|
Re: ... time lines and yet to come...
|
4
|
Resverlogix Corp.
|
Aug 15, 2018 07:00PM
|
|
Re: Vas. Dementia pipeline RVX?
|
4
|
Resverlogix Corp.
|
Dec 07, 2022 01:38PM
|
|
Re: My one-minute commercial for Apabetalone
|
4
|
Resverlogix Corp.
|
Sep 11, 2019 03:59AM
|
|
Re: Question on Rosuvastatin versus Astorvastatin
|
4
|
Resverlogix Corp.
|
Sep 07, 2019 02:27AM
|
|
Re: Sarah's last sentence....
|
4
|
Resverlogix Corp.
|
May 04, 2017 12:54AM
|
|
Re: I guess someone or someones aren't willing to wait....
|
4
|
Resverlogix Corp.
|
Mar 10, 2017 01:39AM
|
|
Re: iceberg or ice cube?
|
4
|
Resverlogix Corp.
|
May 17, 2017 02:30PM
|
|
Re: Just checked the chart again....seeing another wedge
|
4
|
Resverlogix Corp.
|
Apr 04, 2019 08:24PM
|
|
Re: Precedence in Gene Therapy Pricing
|
4
|
Resverlogix Corp.
|
Jan 04, 2018 02:02AM
|
